Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 794930, 9 pages
http://dx.doi.org/10.1155/2014/794930
Review Article

Evaluating the Cancer Therapeutic Potential of Cardiac Glycosides

1Department of Pharmacology, Faculty of Pharmacy, University of Seville, 41012 Seville, Spain
2Department of Cell Biology, Faculty of Biology, University of Seville, Spain

Received 27 February 2014; Revised 25 April 2014; Accepted 28 April 2014; Published 8 May 2014

Academic Editor: Gautam Sethi

Copyright © 2014 José Manuel Calderón-Montaño et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [46 citations]

The following is the list of published articles that have cited the current article.

  • Jianjun Zhang, Larissa V. Ponomareva, Nitin S. Nandurkar, Yaxia Yuan, Lei Fang, Chang-Guo Zhan, and Jon S. Thorson, “Influence of Sugar Amine Regiochemistry on Digitoxigenin Neoglycoside Anticancer Activity,” ACS Medicinal Chemistry Letters, pp. 150818142628001, 2015. View at Publisher · View at Google Scholar
  • Milica M. Labudović Borović, Milan M. Obradović, Jelena T. Kostić, Ivan V. Zaletel, Dejan G. Milašinović, Marija T. Stojanović, Slavica S. Mutavdžin, Milena N. Vesković, Dragan J. Opačić, Dejan D. Radaković, Nela S. Puškaš, Tatjana S. Radosavljević, Saša D. Borović, Zvezdana Z. Kojić, Božidarka L. Zarić, Ljiljana G. Šćepanović, and Esma R. Isenović, “Myocardial Na+ K+-ATPase and SERCA: Clinical and Pathological Significance From a Cytological Perspective,” Regulation of Membrane Na+-K+ ATPase, pp. 113–144, 2015. View at Publisher · View at Google Scholar
  • Miguel López-Lázaro, “A simple and reliable approach for assessing anticancer activity in vitro,” Current Medicinal Chemistry, vol. 22, no. 11, pp. 1324–1334, 2015. View at Publisher · View at Google Scholar
  • Miguel López-Lázaro, “Two preclinical tests to evaluate anticancer activity and to help validate drug candidates for clinical trials,” Oncoscience, vol. 2, no. 2, pp. 91–98, 2015. View at Publisher · View at Google Scholar
  • Peng Sun, Li-xing Feng, Dong-mei Zhang, Miao Liu, Wang Liu, Tian Mi, Wan-ying Wu, Bao-hong Jiang, Min Yang, Li-hong Hu, De-an Guo, and Xuan Liu, “Bufalin derivative BF211 inhibits proteasome activity in human lung cancer cells in vitro by inhibiting β1 subunit expression and disrupting proteasome assembly,” Acta Pharmacologica Sinica, 2016. View at Publisher · View at Google Scholar
  • Anita Aperia, Evgeny E. Akkuratov, Jacopo Maria Fontana, and Hjalmar Brismar, “Na+-K+-ATPase, a new class of plasma membrane receptors,” American Journal Of Physiology-Cell Physiology, vol. 310, no. 7, pp. C491–C495, 2016. View at Publisher · View at Google Scholar
  • Qian Feng, Wa Leong, Liang Liu, and Wai-In Chan, “Peruvoside, a Cardiac Glycoside, Induces Primitive Myeloid Leukemia Cell Death,” Molecules, vol. 21, no. 4, pp. 534, 2016. View at Publisher · View at Google Scholar
  • Dong-Mei Zhang, Li-Xing Feng, Miao Liu, Wen-Hai Jin, Ji Luo, Ai-Ying Nie, Yue Zhou, Yin Li, Wan-Ying Wu, Bao-Hong Jiang, Min Yang, Li-Hong Hu, De-An Guo, and Xuan Liu, “Possible target-related proteins and signal network of bufalin in A549 cells suggested by both iTRAQ-based and label-free proteomic analysis,” Proteomics, vol. 16, no. 6, pp. 935–945, 2016. View at Publisher · View at Google Scholar
  • Seema Patel, “Plant-derived cardiac glycosides: Role in heart ailments and cancer management,” Biomedicine and Pharmacotherapy, vol. 84, pp. 1036–1041, 2016. View at Publisher · View at Google Scholar
  • Guo-Yuan Zhu, Ming Chen, Zhi-Hong Jiang, Supawadee Parhira, and Li-Ping Bai, “Cardenolides from Calotropis gigantea as potent inhibitors of hypoxia-inducible factor-1 transcriptional activity,” Journal of Ethnopharmacology, vol. 194, pp. 930–936, 2016. View at Publisher · View at Google Scholar
  • Lihong Hu, De-An Guo, Xuan Liu, Li-Xing Feng, Peng Sun, Wang Liu, Tian Mi, Min Lei, Miao Liu, Wanying Wu, Baohong Jiang, and Min Yang, “Knockdown of apolipoprotein e enhanced sensitivity of hep3b cells to cardiac steroids via regulating Na+/K+-ATPase Signalosome,” Molecular Cancer Therapeutics, vol. 15, no. 12, pp. 2955–2965, 2016. View at Publisher · View at Google Scholar
  • Mohammad Yahya Alfaifi, “Kanahia laniflora methanolic extract suppressed proliferation of human non-small cell lung cancer A549 cells,” Asian Pacific Journal of Cancer Prevention, vol. 17, no. 10, pp. 4755–4759, 2016. View at Publisher · View at Google Scholar
  • Wolfgang Kreis, and Jennifer Munkert, “Cardiac Glycosides and their Potential Role as Anti-Tumor Agents,” Deutsche Zeitschrift fur Onkologie, vol. 49, no. 3, pp. 129–135, 2017. View at Publisher · View at Google Scholar
  • Ilse Zündorf, Theo Dingermann, and Robert Fürst, “New Knowledge about Old Drugs: The Anti-Inflammatory Properties of Cardiac Glycosides,” Planta Medica, vol. 83, no. 12-13, pp. 977–984, 2017. View at Publisher · View at Google Scholar
  • Walter Bauer, Saulo F. Andrade, Ricardo J. Alves, Cláudia M. O. Simões, Fernão C. Braga, Wolfgang Kreis, Rodrigo Maia De Pádua, Marina Santiago Franco, Elke Nolte, Rachel Oliveira Castilho, Naira F. Z. Schneider, Helge Taubert, Jennifer Munkert, Izabella Thaís Silva, Flaviano Melo Ottoni, and Mônica C. Oliveira, “Production of the Cytotoxic Cardenolide Glucoevatromonoside by Semisynthesis and Biotransformation of Evatromonoside by a Digitalis lanata Cell Culture,” Planta Medica, vol. 83, no. 12-13, pp. 1035–1043, 2017. View at Publisher · View at Google Scholar
  • Wolfgang Kreis, “The Foxgloves (Digitalis) Revisited,” Planta Medica, vol. 83, no. 12-13, pp. 962–976, 2017. View at Publisher · View at Google Scholar
  • Seema Patel, “Phytochemicals for taming agitated immune-endocrine-neural axis,” Biomedicine & Pharmacotherapy, vol. 91, pp. 767–775, 2017. View at Publisher · View at Google Scholar
  • E-J Choi, B-J Jung, S-H Lee, H-S Yoo, E-A Shin, H-J Ko, S Chang, S-Y Kim, and S-M Jeon, “A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer,” Oncogene, 2017. View at Publisher · View at Google Scholar
  • Vivek Kaushik, Juan Sebastian Yakisich, Neelam Azad, Yogesh Kulkarni, Rajkumar Venkatadri, Clayton Wright, Yon Rojanasakul, and Anand Krishnan V. Iyer, “Anti-Tumor Effects of Cardiac Glycosides on Human Lung Cancer Cells and Lung Tumorspheres,” Journal of Cellular Physiology, 2017. View at Publisher · View at Google Scholar
  • Salvador Harguindey, Daniel Stanciu, Jesús Devesa, Khalid Alfarouk, Rosa Angela Cardone, Julian David Polo Orozco, Pablo Devesa, Cyril Rauch, Gorka Orive, Eduardo Anitua, Sébastien Roger, and Stephan J. Reshkin, “Cellular Acidification As A New Approach To Cancer Treatment And To The Understanding And Therapeutics Of Neurodegenerative Diseases,” Seminars in Cancer Biology, 2017. View at Publisher · View at Google Scholar
  • Marzieh Hosseini, Mahboubeh Taherkhani, and Majid Ghorbani Nohooji, “ Introduction of Adonis aestivalis as a new source of effective cytotoxic cardiac glycoside ,” Natural Product Research, pp. 1–6, 2017. View at Publisher · View at Google Scholar
  • Sarah E. Anderson, and Christopher E. Barton, “The cardiac glycoside convallatoxin inhibits the growth of colorectal cancer cells in a p53-independent manner,” Molecular Genetics and Metabolism Reports, vol. 13, pp. 42–45, 2017. View at Publisher · View at Google Scholar
  • Shih-Ming Huang, Min-Huey Chung, Yi-Wen Wang, Yung-Lung Chang, and Wei-Shiang Lin, “Risk of cancer in patients with heart failure who use digoxin: A 10-year follow-up study and cell-based verification,” Oncotarget, vol. 8, no. 27, pp. 44203–44216, 2017. View at Publisher · View at Google Scholar
  • Hugo Juárez Olguín, Mayra Santillán García, David Calderón Guzmán, Ernestina Hernández García, Monica Punzo Soto, and Gerardo Barragán Mejía, “Natural steroids and androgen antagonists used as neuroprotection in common neurological disorders,” CNS and Neurological Disorders - Drug Targets, vol. 16, no. 7, pp. 763–771, 2017. View at Publisher · View at Google Scholar
  • Vivek Kaushik, Neelam Azad, Juan Sebastian Yakisich, and Anand Krishnan V Iyer, “Antitumor effects of naturally occurring cardiac glycosides convallatoxin and peruvoside on human ER+ and triple-negative breast cancers.,” Cell death discovery, vol. 3, pp. 17009, 2017. View at Publisher · View at Google Scholar
  • M. Bartnik, and P.C. Facey, “Glycosides,” Pharmacognosy, pp. 101–161, 2017. View at Publisher · View at Google Scholar
  • Mohd Mutalip Siti-Syarifah, and Yunos Nurhanan-Murni, “Therapeutic Potential of Cardiac Glycosides Against Cancer,” Anticancer Plants: Natural Products and Biotechnological Implements, pp. 67–81, 2018. View at Publisher · View at Google Scholar
  • Veerabhadrappa Bhavana, Setra Janardhana Shetty Sudharshan, and Dyavaiah Madhu, “Natural Anticancer Compounds and Their Derivatives in Clinical Trials,” Anticancer Plants: Clinical Trials and Nanotechnology, pp. 51–104, 2018. View at Publisher · View at Google Scholar
  • Cristiane Loiva Reichert, Denise Brentan da Silva, Carlos Alexandre Carollo, Almeriane Maria Weffort-Santos, and Cid Aimbiré de Moraes Santos, “Metabolic profiling and correlation analysis for the determination of killer compounds of proliferating and clonogenic HRT-18 colon cancer cells from Lafoensia pacari,” Journal of Ethnopharmacology, 2018. View at Publisher · View at Google Scholar
  • Isabelle Laverdière, Meaghan Boileau, Andrea L. Neumann, Héloïse Frison, Amanda Mitchell, Stanley W. K. Ng, Jean C. Y. Wang, Mark D. Minden, and Kolja Eppert, “Leukemic stem cell signatures identify novel therapeutics targeting acute myeloid leukemia,” Blood Cancer Journal, vol. 8, no. 6, 2018. View at Publisher · View at Google Scholar
  • Beste Turanli, Morten Grøtli, Jan Boren, Jens Nielsen, Mathias Uhlen, Kazim Y. Arga, and Adil Mardinoglu, “Drug Repositioning for Effective Prostate Cancer Treatment,” Frontiers in Physiology, vol. 9, 2018. View at Publisher · View at Google Scholar
  • Yangyang He, Shili Yu, Muhammad Khan, Jingbo Yang, Min Yao, and Hongwen Gao, “Proscillaridin a induces apoptosis, inhibits STAT3 activation and augments doxorubicin toxicity in prostate cancer cells,” International Journal of Medical Sciences, vol. 15, no. 8, pp. 832–839, 2018. View at Publisher · View at Google Scholar
  • Fei Chen, Jie Du, Ting Xie, Fenju Liu, Jun Shang, Yushuo Zhang, Narui Yin, Haowen Zhang, and Jiahua Yu, “A CRISPR/Cas9-based screening for non-homologous end joining inhibitors reveals ouabain and penfluridol as radiosensitizers,” Molecular Cancer Therapeutics, vol. 17, no. 2, pp. 419–431, 2018. View at Publisher · View at Google Scholar
  • Daniel M. Zuckerman, Shanhang Jia, D. Lansing Taylor, Shannon L. Puhalla, Steffi Oesterreich, Adrian V. Lee, Andrew M. Stern, Mark T. Miedel, Ryan Hessenius, Ning Chen, Zhijie Ding, Tong Ying Shun, Marilyn Ngo, Peilu Wang, Amir Bahreini, and Zheqi Li, “Clinically Observed Estrogen Receptor Alpha Mutations within the Ligand-Binding Domain Confer Distinguishable Phenotypes,” Oncology (Switzerland), vol. 94, no. 3, pp. 176–189, 2018. View at Publisher · View at Google Scholar
  • Ana Flávia M. Botelho, Felipe Pierezan, Benito Soto-Blanco, and Marília Martins Melo, “A review of cardiac glycosides: structure, toxicokinetics, clinical signs, diagnosis and antineoplastic potential,” Toxicon, 2018. View at Publisher · View at Google Scholar
  • Letícia Vieira, Aline Aparecida Saldanha, Andreza Marinho Moraes, Flávio Martins de Oliveira, Débora Oliveira Lopes, Leandro Augusto de Oliveira Barbosa, Rosy Iara Maciel de Azambuja Ribeiro, Ralph Gruppi Thomé, Hélio Batista dos Santos, José Augusto Ferreira Perez Villar, and Adriana Cristina Soares, “21‑Benzylidene digoxin, a novel digoxin hemi-synthetic derivative, presents an anti-inflammatory activity through inhibition of edema, tumour necrosis factor alpha production, inducible nitric oxide synthase expression and leucocyte migration,” International Immunopharmacology, vol. 65, pp. 174–181, 2018. View at Publisher · View at Google Scholar
  • Young Ko, Trojan Rugira, Hana Jin, Sang Park, and Hye Kim, “Oleandrin and Its Derivative Odoroside A, Both Cardiac Glycosides, Exhibit Anticancer Effects by Inhibiting Invasion via Suppressing the STAT-3 Signaling Pathway,” International Journal of Molecular Sciences, vol. 19, no. 11, pp. 3350, 2018. View at Publisher · View at Google Scholar
  • Sandeep Kumar Verma, Ashok Kumar Das, Saikat Gantait, Songul Gurel, and Ekrem Gurel, “Influence of auxin and its polar transport inhibitor on the development of somatic embryos in Digitalis trojana,” 3 Biotech, vol. 8, no. 2, 2018. View at Publisher · View at Google Scholar
  • Amara Maryam, Tahir Mehmood, Qiulong Yan, Yongming Li, Muhammad Khan, and Tonghui Ma, “Proscillaridin A Promotes Oxidative Stress and ER Stress, Inhibits STAT3 Activation, and Induces Apoptosis in A549 Lung Adenocarcinoma Cells,” Oxidative Medicine and Cellular Longevity, vol. 2018, pp. 1–17, 2018. View at Publisher · View at Google Scholar
  • Kedibone G. Kgosana, “The effects of extraction techniques and quantitative determination of oxalates in Nerium oleander and feeds,” Onderstepoort Journal of Veterinary Research, vol. 86, no. 1, 2019. View at Publisher · View at Google Scholar
  • Chien-shan Cheng, Jiaqiang Wang, Jie Chen, Kuei Ting Kuo, Jian Tang, Huifeng Gao, Lianyu Chen, Zhen Chen, and Zhiqiang Meng, “New therapeutic aspects of steroidal cardiac glycosides: the anticancer properties of Huachansu and its main active constituent Bufalin,” Cancer Cell International, vol. 19, no. 1, 2019. View at Publisher · View at Google Scholar
  • Vahap Murat Kutluay, Toshiaki Makino, Makoto Inoue, and Iclal Saracoglu, “New knowledge about old drugs; a cardenolide type glycoside with cytotoxic effect and unusual secondary metabolites from Digitalis grandiflora Miller,” Fitoterapia, vol. 134, pp. 73–80, 2019. View at Publisher · View at Google Scholar
  • Md Shahadat Hossan, Zi-Yang Chan, Hilary M. Collins, Fiona N. Shipton, Mark S. Butler, Mohammed Rahmatullah, Jong Bong Lee, Pavel Gershkovich, Leonid Kagan, Teng-Jin Khoo, Christophe Wiart, and Tracey D. Bradshaw, “Cardiac glycoside Cerberin exerts anticancer activity through PI3K/AKT/mTOR signal transduction inhibition,” Cancer Letters, 2019. View at Publisher · View at Google Scholar
  • Duane Gischewski Pereira, Mariana Manzano Rendeiro, Vanessa Faria Cortes, Leandro Augusto Barbosa, and Luis Eduardo M. Quintas, “Antagonistic anticancer effect of paclitaxel and digoxin combination,” Journal of Cellular Biochemistry, 2019. View at Publisher · View at Google Scholar
  • Hem Raj Khatri, Bijay Bhattarai, Will Kaplan, Zhongzheng Li, Marcus John Curtis Long, Yimon Aye, and Pavel Nagorny, “Modular Total Synthesis and Cell-Based Anticancer Activity Evaluation of Ouabagenin and Other Cardiotonic Steroids with Varying Degrees of Oxygenation,” Journal of the American Chemical Society, 2019. View at Publisher · View at Google Scholar
  • Wenxin Xu, and Glenn J. Bubley, “Repurposed Drugs for Prostate Cancer,” The Cancer Journal, vol. 25, no. 2, pp. 121–126, 2019. View at Publisher · View at Google Scholar